...
首页> 外文期刊>Diabetes >Hepatic Stearoyl-coa Desaturase (scd)-l Activity And Diacylglycerol But Not Ceramide Concentrations Are Increased In The Nonalcoholic Human Fatty Liver
【24h】

Hepatic Stearoyl-coa Desaturase (scd)-l Activity And Diacylglycerol But Not Ceramide Concentrations Are Increased In The Nonalcoholic Human Fatty Liver

机译:在非酒精性人类脂肪肝中,肝硬脂酰-Coa去饱和酶(scd)-1活性和二酰基甘油但神经酰胺浓度没有增加

获取原文
获取原文并翻译 | 示例

摘要

Objective-To determine whether 1) hepatic ceramide and diacylglycerol concentrations, 2) SCD1 activity, and 3) hepatic lipogenic index are increased in the human nonalcoholic fatty liver.rnResearch Deesign and Meethods -We studied 16 subjects with (n = 8) and without (n = 8) histologically determined nonalcoholic fatty liver (NAFL~+ and NAFLT~-) matched for age, sex, and BMI. Hepatic concentrations of lipids and fatty acids were quantitated using ultra-performance liquid chromatography coupled to mass spectrometry and gas chromatography.rnResults-The absolute (nmol/mg) hepatic concentrations of diacylglycerols but not ceramides were increased in the NAFL~+ group compared with the NAFL~- group. The livers of the NAFL~+ group contained proportionally less long-chain polyunsaturated fatty acids as compared with the NAFL~- group. Liver fat percent was positively related to hepatic stearoyl-CoA desaturase 1 (SCD1) activity index (r = 0.70, P = 0.003) and the hepatic lipogenic index (r = 0.54, P = 0.030). Hepatic SCD1 activity index was positively related to the concentrations of diacylglycerols (r = 0.71, P = 0.002) but not ceramides (r = 0.07, NS).rnConclusions-We conclude that diacylglycerols but not ceramides are increased in NAFL. The human fatty liver is also characterized by depletion of long polyunsaturated fatty acids in the liver and increases in hepatic SCD1 and lipogenic activities. Diabetes 58:203-208, 2009
机译:目的-确定人类非酒精性脂肪肝中1)肝神经酰胺和二酰基甘油的浓度,2)SCD1活性和3)肝脂肪生成指数是否升高。研究设计和方法-我们研究了16名有(n = 8)和没有(n = 8)的受试者(n = 8)经组织学确定的非酒精性脂肪肝(NAFL〜+和NAFLT〜-)与年龄,性别和BMI相匹配。结果:与NAFL〜+组相比,NAFL〜+组中的二酰基甘油的绝对肝脏(nmol / mg)绝对浓度(nmol / mg)升高,而神经酰胺未升高。 NAFL〜-组。与NAFL-组相比,NAFL- +组的肝脏按比例减少了长链多不饱和脂肪酸的含量。肝脂肪百分比与肝硬脂酰辅酶A去饱和酶1(SCD1)活性指数(r = 0.70,P = 0.003)和肝脂肪生成指数(r = 0.54,P = 0.030)正相关。肝SCD1活性指数与二酰基甘油的浓度呈正相关(r = 0.71,P = 0.002),而不与神经酰胺(r = 0.07,NS)相关。rn结论-我们得出结论:NAFL中的二酰基甘油而不是神经酰胺增加。人脂肪肝的特征还在于肝脏中长链多不饱和脂肪酸的消耗,肝SCD1和脂肪形成活性的增加。糖尿病58:203-208,2009年

著录项

  • 来源
    《Diabetes》 |2009年第1期|203-208|共6页
  • 作者单位

    Department of Medicine, Division of Diabetes, Helsinki, Finland Minerva Medical Research Institute, Helsinki, Finland;

    VTT Technical Research Centre of Finland, Espoo, Finland;

    Department of Medicine, Division of Diabetes, Helsinki, Finland;

    Department of Surgery, University of Helsinki, Helsinki, Finland;

    Department of Pathology, University of Helsinki and HUSLAB, Helsinki, Finland;

    VTT Technical Research Centre of Finland, Espoo, Finland;

    VTT Technical Research Centre of Finland, Espoo, Finland;

    Department of Medicine, Division of Diabetes, Helsinki, Finland;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号